Biggest News Aggregation in the World
📰 Phra News

Page 24 - Phra News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Phra. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Global Blood Therapeutics, Inc.: MHRA Grants Marketing Authorization for GBT's Oxbryta (voxelotor) for Use in Great Britain for the Treatment of Hemolytic Anemia in Patients with Sickle Cell Disease Age 12 Years and Older

Voxelotor is the first medicine approved in Great Britain to directly inhibit sickle hemoglobin (HbS) polymerization, the underlying molecular cause of sickle cell diseaseSOUTH SAN FRANCISCO, Calif., July
United States United Kingdom Great Britain Informationfor Oxbryta Steven Immergut Courtney Roberts

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science